Evidence map›Paper›PMID 36431142›Full record

ArticleJournal of clinical medicine2022

Clinicopathological Correlation of Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study.

Ziyi Chang, Jixiang Liu, Bei Wang, Honglei Zhang, Ling Zhao, Yunchao Su, Wanmu Xie, Qiang Huang, Yanan Zhen, Fan Lin and 9 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Ziyi ChangDepartment of Pathology, China-Japan Friendship Hospital, Beijing 100029, China.ORCID 0000-0002-0417-9998
Jixiang LiuDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.ORCID 0000-0001-6904-320X
Bei WangDepartment of Pathology, China-Japan Friendship Hospital, Beijing 100029, China.
Honglei ZhangDepartment of Pathology, China-Japan Friendship Hospital, Beijing 100029, China.
Ling ZhaoDepartment of Pathology, China-Japan Friendship Hospital, Beijing 100029, China.
Yunchao SuDepartment of Pathology, China-Japan Friendship Hospital, Beijing 100029, China.
Wanmu XieDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
Qiang HuangDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
Yanan ZhenDepartment of Cardiovascular Surgery, China-Japan Friendship Hospital, Beijing 100029, China.
Fan LinDepartment of Cardiovascular Surgery, China-Japan Friendship Hospital, Beijing 100029, China.
Min LiuDepartment of Radiology, China-Japan Friendship Hospital, Beijing 100029, China.
Qian GaoDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
Wenyi PangDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
Zhu ZhangDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
Han TianDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
Yishan LiDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.
Peiran YangNational Clinical Research Center for Respiratory Diseases, Beijing 100029, China.ORCID 0000-0002-4635-1215
Zhenguo ZhaiDepartment of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China.ORCID 0000-0002-7096-8792
Dingrong ZhongDepartment of Pathology, China-Japan Friendship Hospital, Beijing 100029, China.
China-Japan Friendship Hospital · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNShanxi Medical University · CN

Funding

National Natural Science Foundation of China 81970058Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2020-PT320-001Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences 2021-RC310-016the Fund of CAMS Innovation Fund for Medical Sciences 2021-I2M-1-049
6 · The paper itself

Abstract

The pathophysiology of chronic thromboembolic pulmonary hypertension (CTEPH) is largely unknown. Although pulmonary endarterectomy (PEA) is potentially curative, inoperable patients and persistent pulmonary hypertension (PH) following surgery remain a significant problem. In this study, we aim to describe the histopathological characteristics of CTEPH and explore the potential relationship between pulmonary arterial lesions, radiological parameters, and clinical manifestations. Endarterectomized tissues from 81 consecutive patients of CTEPH were carefully collected, sectioned, and examined by experienced pathologists. Pertinent clinical and radiological data were obtained from medical records and operative reports. Neointima, fresh/organized thrombi, recanalized regions, and atherosclerotic lesions were microscopically examined as previously described. Thrombi and atherosclerosis were dominant in UCSD classification level I PEA materials, while recanalized neo-vessels were more frequently observed in UCSD classification level III cases. Degenerative changes of the extracellular matrix were also noticed in the vascular bed. Atherosclerotic lesions were more frequently observed in cases with higher ratio of the pulmonary artery diameter to ascending aorta diameter (PA/AA) reflected by computed tomographic pulmonary arterial scanning. Furthermore, the removal of pulmonary artery complex lesions (with the combination of three to four types of lesions) by PEA was associated with lower postoperative mean pulmonary arterial pressure (mPAP) and decreased incidences of persistent PH. Our study demonstrates that the histopathological features of CTEPH are strongly linked with clinical manifestations and the postoperative outcome after PEA. These data may provide possible evidence for further studies in searching for appropriate causal factors underlying this disease.

Indexed as

atherosclerosischronic thromboembolic pulmonary hypertensionpathologypersistent pulmonary hypertensionpulmonary endarterectomy

Identifiers

PMID36431142
PMCPMC9694879
OpenAlexW4308803119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.